Literature DB >> 7122039

Decreased endothelial permeability in the iridocorneal endothelial syndrome.

W M Bourne, R F Brubaker.   

Abstract

Five patients with the iridocorneal endothelial (ICE) syndrome were examined by fluorophotometry. All patients had typical abnormal corneal endothelium, peripheral anterior synechiae, and distortion of the iris (pupillary irregularity or anterior stromal traction tears) in one eye only. Fluorescein was deposited in the superior cornea of both eyes by iontophoresis, and the cornea and anterior chamber concentrations and total mass of fluorescein were measured hourly over the ensuing eight hours. In all five patients, the endothelial permeability to fluorescein was within normal limits in the normal eye. In four of the five abnormal eyes, endothelial permeability was markedly decreased. In these four patients, the permeability to fluorescein in the normal eye was approximately six times that in the abnormal eye. In the fifth patient, the endothelial permeability was normal in both eyes. The central corneal thicknesses were normal in both eyes of all five patients. These results indicate that in many eyes with the ICE syndrome, corneal endothelial permeability to solutes is markedly decreased. Decreased endothelial permeability to solutes has not been documented previously in any clinical corneal disorder and may be of importance in the pathophysiologic changes that accompany endothelial disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7122039     DOI: 10.1016/s0161-6420(82)34745-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Pathogenesis of the ICE syndrome.

Authors:  R J Buckley
Journal:  Br J Ophthalmol       Date:  1994-08       Impact factor: 4.638

2.  Corneal endothelial cell abnormalities in an early stage of the iridocorneal endothelial syndrome.

Authors:  W R Lee; G E Marshall; C M Kirkness
Journal:  Br J Ophthalmol       Date:  1994-08       Impact factor: 4.638

Review 3.  Recent advances in ophthalmic drug delivery.

Authors:  Uday B Kompella; Rajendra S Kadam; Vincent H L Lee
Journal:  Ther Deliv       Date:  2010-09

4.  Morphologic and functional evaluation of the endothelium of transplanted human corneas.

Authors:  W M Bourne
Journal:  Trans Am Ophthalmol Soc       Date:  1983

5.  Endothelial barrier function after phacoemulsification: a comparison between diabetic and non-diabetic patients.

Authors:  M Goebbels; M Spitznas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

6.  Progression and regression of partial corneal involvement in the iridocorneal endothelial syndrome.

Authors:  W M Bourne; R F Brubaker
Journal:  Trans Am Ophthalmol Soc       Date:  1992

7.  Cornea thinning in two cases of ICE syndrome.

Authors:  Morgan M Harvey; Joseph W Schmitz
Journal:  BMJ Case Rep       Date:  2020-09-28

Review 8.  Diagnosis and Management of Iridocorneal Endothelial Syndrome.

Authors:  Marta Sacchetti; Flavio Mantelli; Marco Marenco; Ilaria Macchi; Oriella Ambrosio; Paolo Rama
Journal:  Biomed Res Int       Date:  2015-09-16       Impact factor: 3.411

Review 9.  Cx43-hemichannel function and regulation in physiology and pathophysiology: insights from the bovine corneal endothelial cell system and beyond.

Authors:  Catheleyne D'hondt; Jegan Iyyathurai; Bernard Himpens; Luc Leybaert; Geert Bultynck
Journal:  Front Physiol       Date:  2014-09-12       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.